search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
22


ADVERTISEMENT FEATURE


COVER STORY: ASHLAND Glossymeter result


2.50 2.00 1.50 1.00 0.50 0.00


Placebo ■ 5% collapeptyl™ ■ 48% **


Boosting 20 collagen chains of the skin collaverse™ We first investigated the synergistic effect of our bifunctional in ex vivo skin on the level of two key markers of skin, collagen I and hyaluronic acid. The topical application of 5% collapeptyl™ on normal skin biopsies was associated with an observed increase in collagen I and hyaluronic acid contents after 48 hours (+ 44% and +57% respectively) (Figure 2). Solutions containing each constituent isolated of collapeptyl™ at the same concentration found in 5% collapeptyl™, applied on the same ex vivo skin, showed a smaller effect than collapeptyl™. Moreover, if we combine the effect of each component of collapeptyl™ given separately, collapeptyl™ effect is greater, demonstrating the synergistic effect of collapeptyl™(Figure 2). Secondly, the effect of collapeptyl™ was studied on different parts of the collagen family. which comprises 28 members, 20 of which are skin related in what we call the collaverse™. Based on their structural and functional properties, this collaverse™ superfamily can be divided into several categories. The best represented category is fibril-forming collagens, including collagens I and III, which constitute over 90% of skin’s collagen content. The others, nonfibrils-forming collagens, are divided into 7 categories: fibrils-associated collagens, network-forming collagens, multiplexin collagens, beaded filament-forming collagen, transmembrane collagens, anchoring fibrils and hexagonal network-forming collagens.5 Even if these collagens are considered as a minority in skin, their roles are essential in cell anchorage, structural function and signaling.6 The sequences of peptides used in


collapeptyl™ match with 20 collagens sequences. Thus, during this study, the effect of collapeptyl™ was investigated on the expression of 20 collagen-chains distributed in the 8 collagen’s categories on skin biopsies, on in vitro fibroblasts and keratinocytes either by immunostaining or by qPCR. The results obtained following the application of 5% collapeptyl™ on ex vivo skin or 0.5% of collapeptyl™ on in vitro cells, showed an enhancement in all collagens studied and were summarized in Figure 2.


T4h-T0 T0


Fine lines smoothness after 5% collapeptyl™ mask application T30min


T4h


Exploring collapeptyl™ as a sensorial booster The sensorial effect of collapeptyl™, provided by the cellulose gum part, was assessed by comparing a formula containing 5% collapeptyl™ with a formula containing 5% silicone, on two different blind panels (8 experts and 10 non-experts). Both panelists found that the cream containing collapeptyl™ had the same texturing effect than the silicone formulation with a better quick break and playtime highlighting the texturing effect of the biofunctional (Figure 3).


Asian women, 50-year-old Figure 4: Glow and smooth effect of 5% collapeptyl™ biofunctional on Asian volunteers PERSONAL CARE April 2025


Visual skin benefits, tested on Caucasian and Asian panel Two clinical double-blind studies were designed to highlight the interest to combine


www.personalcaremagazine.com


ΔSkin glossy value


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132